| Literature DB >> 25740152 |
Peggy Sextius1, Claire Marionnet, Charlotte Tacheau, François-Xavier Bon, Philippe Bastien, Alain Mauviel, Bruno A Bernard, Françoise Bernerd, Louis Dubertret.
Abstract
With aging, epidermal homeostasis and barrier function are disrupted. In a previous study, we analyzed the transcriptomic response of young skin epidermis after stratum corneum removal, and obtained a global kinetic view of the molecular processes involved in barrier function recovery. In the present study, the same analysis was performed in aged skin in order to better understand the defects which occur with aging. Thirty healthy male volunteers (67 ± 4 years old) were involved. Tape-strippings were carried out on the inner face of one forearm, the other unstripped forearm serving as control. At 2, 6, 18, 30 and 72 h after stripping, TEWL measurements were taken, and epidermis samples were collected. Total RNA was extracted and analyzed using DermArray(®) cDNA microarrays. The results highlighted that barrier function recovery and overall kinetics of gene expression were delayed following stripping in aged skin. Indeed, the TEWL measurements showed that barrier recovery in the young group appeared to be dramatically significant during the overall kinetics, while there were no significant evolution in the aged group until 30 h. Moreover, gene expression analysis revealed that the number of modulated genes following tape stripping increased as a function of time and reached a peak at 6 h after tape stripping in young skin, while it was at 30 h in aged skin, showing that cellular activity linked to the repair process may be engaged earlier in young epidermis than in aged epidermis. A total of 370 genes were modulated in the young group. In the aged group, 382 genes were modulated, whose 184 were also modulated in the young group. Only eight genes that were modulated in both groups were significantly differently modulated. The characterization of these genes into 15 functional families helped to draw a scenario for the aging process affecting epidermal repair capacity.Entities:
Mesh:
Year: 2015 PMID: 25740152 PMCID: PMC4409645 DOI: 10.1007/s00403-015-1551-5
Source DB: PubMed Journal: Arch Dermatol Res ISSN: 0340-3696 Impact factor: 3.017
Fig. 1Kinetics of barrier function recovery as assessed by TEWL measurements before, immediately after and 02, 06, 18, 30 and 72 h after TS. A percentage of barrier recovery was calculated at each time after TS. The mean TEWL value that was obtained immediately after SC removal was set to 0 %, and the mean initial TEWL value obtained before aggression was set to 100 %. The evolution of barrier recovery has been displayed using a boxplot representation. The line and the circle inside the boxes represent the median and the mean of barrier function recovery, respectively
Functional characterization of genes whose expression was modulated following tape stripping
| Main functional groups | Description |
|
| Modulated genes (gene symbols) | ||
|---|---|---|---|---|---|---|
| 186 specific for young group | 184 common to young and aged group | 198 specific for aged group | ||||
| 1. Transport | Movement and regulation of proteins into, out of, within, between cells | 15 | 11 | SLC16A1; SNX2; SUOX; SYT1; ARF1; RAB5A; ARL4D; SLC6A1; KLHL32 | KPNB1; SULT1C2; RAB7A; ARF1; RAB1A; ARF4 | AP2S1; SEC61B; NGB; ABCB8; SERPINA3 |
| 2. Adhesion | Attachment/regulation of a cell to another cell or to extracellular matrix | 17 | 16 | DSC2; HAPLN1; EMB; CD44; ADAM15; CDH3; PXN; ITGB5; PTPRF; CDH1; CTNNA1 | SDC4; PTK7; ARHGDIA; GJB2; POSTN; ITGA6 | CNTNAP1; IL8; ITGA3; ITGAE; ITGB1BP1; ICAM3; LGALS2; CDH8; ADRM1 |
| 3. Detoxification–oxidative stress | Processes that reduce or remove toxicity, response to oxidative stress | 14 | 20 | GLRX; GSTM5 | SLC25A5; ATP5I; PRNP; HSP90B1; RPS6; MT1E; ATP5O; NDUFV2; GSTP1; HSP90AB1; SDHA | UQCRQ; GSTA4; ATP5F1; ATP5C1; GPX3; ATP5D; NDUFB9; ETFA |
| 4. Cellular matrix | Cellular matrix constituent | 19 | 15 | SPTA1; KIF3C; PLEC1; LMNA; ARPC3; TUBB3; GSN; ARPC3; TUBB4 | CBX3; TMSB4X; TUBA3C; LOC643224; TUBA1B; TUBB2A; ACTR3; ACTB; LAD1 | TUBA3C; ARPC1A; PFN1; ARPC4; ARPC2 |
| 5. Immune response | Processes related to immune response, to immune system and regulation | 20 | 19 | PTGES; MLF2; ABCF1; LILRB2; THBD; CTSE; LCP2; NCDN; CD55; ICAM1 | S100A8; YBX1; TMSB4X; PPIC; AZGP1P1; IFITM2; AZGP1; S100A9; CD59; ANXA1 | BCRP1(BANF1, ABCG2); IFI17; IFI27; CLEC2B; IFNGR2; ANXA5; D4S234E; CD36; HAX1 |
| 6. Communication | Processes that mediate interactions between a cell and its surroundings, cell signaling | 33 | 25 | RGS4; KDR; PRKCH; TBL3; ZFP36L1(BRF1); EFNB1; DLGAP4; PRKCB1; IFNAR2; VRK3; PTK2; GLG1; YWHAE; DIO3; NR4A1; MAPK10; GNAO1; GNAZ; EPHB2 | CRHBP; S100A10; EPHB3; S100A2; GJA1; CSNK1A1; PTGES3; FOSL1; DUSP7; CALM2; PTP4A2; JUNB; SIGMAR1 | GNAI2; PIK3CD; TRAP1; PTP4A2; RUNDC3A; IRAK1; TLE4; MAP2K3; EFNA1; PRKCG; HINT1; MAPKAPK3 |
| 7. Cell cycle growth–proliferation | Cell replication, increase in size, expansion of the cell population, cell division | 37 | 32 | FLT1; HBEGF; PLAU; BST2; EGR1; CCNG2; IFI16; IGFBP3; SLC3A2; VAT1; KHDRBS1; MAPK6; CDK6; NDUFA5; PMP22; CAP1; TSPAN31; SYK; HBEGF; CXCL1 | BZW1; HDGF; KLK10; MYC; PPM1G; PA2G4; YWHAQ; NME1; NPM1; CAPNS1; PRDX1; AREG; FGFBP1; SEPT2; KLF4; FOSB | TCF3; TSPAN-3; UBE2C; PCNA; CDC37; DDX5; EWSR1; LMO2; IGFBP6; ISG20; ARPC2; SOCS1; GSPT1; MYL4; PHB; CDK2AP1 |
| 8. DNA–RNA–transcription–translation | DNA synthesis, repair, amplification, RNA processing, splicing-transcription and translation processing and regulation | 72 | 70 | RBM3; ST18; SAP18; EIF4E; MEF2A; IARS; PLAG1; XRCC1; METAP2; NRAS; PCBP1; RNPS1; CRYAB; DDB1; SSX3; RPL24; FBL; HMGB1; PAR5; SF3B4; H2AFB2; MEF2D; LOC646171; PURA; ZFP36; EGR3; CHAF1B; HARS; CDC27 | EIF2S2; KLF6; SUB1; HNRPA1; SNRPG; SFRS2; SF1; RPP30; EIF1; NCL; SRPR; SNRPB; CACNA1I; H3F3B; SET; LDHB; GARS; TRIM28; SNRPF; XRCC5; CCT6A; POLR2L; JUNB; JUNB; HNRNPA1; EBNA1BP2; EIF2S2; CCT3; SFRS1; HNRPA2B1; HNRNPABHNRNPA1; EBNA1BP2; EIF2S2; CCT3; SFRS1; HNRPA2B1; HNRNPABNOP56; HNRNPC; CCT6A; EIF4A1; SNRPD1; BGN; EIF4A3; NCL; JUNB; HNRNPA1; EBNA1BP2; EIF2S2; CCT3; SFRS1; HNRPA2B1; HNRNPAB | SNRPA1; SFRS6; SYNCRIP; PPIF; BUD31; POLR2F; SRP72; POLR2G; ZNF212; KDELR3; KARS; HNRPR; SFRS4; LRRFIP1(EPRS); RPA1; TCEB2; SF3B2; NASP; EIF3B; PTBP1; HNF1B; EIF4EBP2 (SSBP3); HIST1H4C; TRAB2; POLR2D; SSBP1; ARD1A; BTF3 |
| 9. Proteolysis | Hydrolysis of a peptide bond or bonds within a protein | 20 | 25 | UBE2D2; PSMD8; UBA1; METAP2; UBA1; SERPINB8 | PSMC1; SERPINB3; PSMD2; PSMA3; PSME3; PSMB7; RPL32; PSMB5; P11; PSMD2; CSTB; PSMB1; MMP3; CSTA | ECE1; PSMC3; TRB@; PSMD6; USP10; COPS3; PSMA5; PSMB3; PSMA7; PSME2; PGA3 |
| 10. Energy | Processes involved in the liberation of energy | 23 | 26 | PCK1; SMPD1; COX8A; CYP2S1; ATP2A2; DLD; ABCE1 | COX6A1; PGK1; PGAM1; TPI1; CYC1(CYCS); ALDOA; NDUFA11; LDHA; GAPDH; COX6B1; DPYS; CHST11; COMT; CYC1(CYCS); SULT2B1 | NDUFB4; NDUFS1; CYP3A4; CYC1; LDHC; COX7C; COX7B; BPGM; CA2; QDPR; COX6C |
| 11. Cell differentiation | Acquisition of specialized structural and/or the functional features that characterize the mature cells | 20 | 22 | EVPL; KRT20; NDRG1; ECM1 | KRT6B; KRT5; SPRR2C; SPRR1B; 0SPINT1; KRT10; S100A7; KRT16; KRT8; KRT4; KRT18; FLG; IVL; KRT14; KRT13 | INHBB; KRT7; KRT1; TGM1; KRT13 |
| 12. Lipids (barrier function) | Synthesis, metabolism and processing of the lipids of lamellar bodies or involved in barrier function | 5 | 4 | PLCL1; ADFP; CTSA; FDPS | ACAT2 | GM2A; HSD17B10; NSUN4 |
| 13. Apoptosis | Genes related to apoptosis and regulation of apoptosis | 6 | 11 | API5L1; DAD1; TMBIM6; SST; NFKBIA | SERPINB2 | TIMP3; MAP3K5; PDCD5; APP; EI24; PDCD6; IL2RA; DAPK3; BAK1; DNASE1L3 |
| 14. Diverse (weakly represented functional groups : contain <5 genes) | Apoptosis, amino acid metabolism, melanin synthesis, Golgi apparatus, development, lipid metabolism, extracellular matrix, ion transport, nucleotide synthesis | 26 | 36 | HPD; MMP7; SLC31A1; GOLGA4; BMP4; DRG1; VSNL1; DCT; PAICS; CACNA2D2; PMEL; SST; BGN | MMP1; TYRP1; P4HB; ARG1; ODC1; CLIC1; MYL12A; OAZ1; NME2; SLC4A3; SRM; MT1L; P4HB; CALU; SERPINB2 | FXYD3; CANX; TSTA3; ROR1; PRRG2; KTN1; CRIP2; GOT2; COL1A2; APRT; APP; COL6A2; ANXA6; ATP1A1; PTS; MT1G; MT1B; MT1H; MT1F; IMPDH1; CTBP1; HAL |
| 15. Unknown | Expressed genes with undefined ontology | 43 | 50 | FAM83A; ANXA8L1; HNRNPL; JMJD4; ITGAM; FAM82B; IFT140; FAM160A2; ARL4D; IGHM; NAPEPLD; NCDN; TIMP1; EIF1; SAT1; TOP1; CYC1; IL3RA; ZNF740 | TREML2; RCVRN; NAMPT; GNL2; HNRNPA3; FAM129B; PTMA | ATXN2L; SART1; ESRRA; ALDH18A1; AURKAIP1; PTCH1; CCDC40; PSMC6; SSSCA1; HN1; DDR1; MCRS1; CD99L2; NQO2; FCN1; IGHV5-78; NID1; SUMO2; COX16; FGA; TUBG1; CD52(TMEM126A), TMEM50A; TAGLN2; SYNPO; PPY2; ITPKC; RPS29; EWSR1; FGF2; PLAC2; MT1F; TUBG1; CD52(TMEM126A) |
| Total | 370 | 382 | ||||
N number of modulated genes, Y young group, A aged group
Fig. 2Characterization of gene expression during epidermal repair in young and aged epidermis. The 370 modulated genes in young epidermis and 382 modulated genes in aged epidermis were classified by using (1) the hierarchical clustering method (a young epidermis, b aged epidermis); (2) a kinetic distribution graphic (c)
Time distribution of modulated genes in young and aged skin as a function of the functional group they belong to
The shading darkens as the number of modulated genes increases
Eight genes that were significantly differentially modulated in young and aged skin
The mean fold change values at 6 and 30 h are reported at log 2 scale. Those with bold characters correspond to those that were considered as significantly modulated as defined in the methods. If there were >0.9 = up-regulation, or if <−0.6 = down regulation. A two-way Anova test was performed to compare aged and young groups. The significances of the age factor (a) and of the interaction of age on time (i) are reported
The shading darkens as the intensity of gene modulation increases
* Significant (Anova test, p value <0.05)
** Highly significant (Anova test, p value <0.01)
Fig. 3Example of four genes whose expression profiles after TS were significantly different between young and aged epidermis. The curves represent modulations of gene expression at log2 scale as a function of time. (a SPRR1B, b KRT6B, c ICAM1, d COX7B)
23 genes that were specifically modulated in young skin: The mean fold change values at 6 and 30 h are reported at log2 scale
| Functional group | Total | Gene symbol | Gene name | Young | Aged |
| |||
|---|---|---|---|---|---|---|---|---|---|
| 6 h | 30 h | 6 h | 30 h | 6 h | 30 h | ||||
| Adhesion | 3 | ADAM15 | A disintegrin and metalloproteinase domain 15 (metargidin) |
| 0.48 | 0.03 | 0.69 | 0.06* | 0.25 |
| CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) |
| 0.40 | 0.56 | 0.32 | 0.01** | 0.93 | ||
| ITGAM | Integrin, alpha M (complement component 3 receptor 3 subunit) |
| 0.43 | 0.39 | 0.22 | 0.86 | |||
| Cell cycle–growth–proliferation | 1 | KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 |
| 0.58 | 0.04 | 1.22 | 0.04** | 0.4 |
| Cellular matrix | 1 | TUBB4 | Tubulin, beta 4 |
| 0.95 | 0.82 | 0.90 | 0.11 | 0.93 |
| Communication | 2 | CAP1 | CAP, adenylate cyclase-associated protein 1 |
| 0.31 | 0.18 | 0.7 | 0.02** | 0.33 |
| IFNAR2 | Interferon (alpha, beta and omega) receptor 2 |
| 0.47 | 0.53 | −0.1 | 0.39 | 0.06* | ||
| DNA–RNA–transcription–translation | 6 | XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 |
| 0.44 | 0.41 | 0.15 | 1 | |
| H2AFB2 | H2A histone family, member B2 |
| 0.81 | 0.14 | 0.05** | 0.07* | |||
| RNPS1 | RNA binding protein S1, serine-rich domain |
| 0.58 | 0.08 | 0.35 | 0.03** | 0.76 | ||
| SAP18 | Sin3A-associated protein, 18 kDa |
| 0.95 | 0.79 | 0.79 | 0.02** | 0.73 | ||
| EIF1 | Eukaryotic translation initiation factor 1 |
| 0.45 | −0.34 | 0.44 | 0.02** | 1 | ||
| ARL4D | ADP-ribosylation factor-like 4D |
| 0.24 | 0.29 | 0.1 | 0.06* | 0.762 | ||
| Immune response | 3 | IL3RA | Interleukin 3 receptor, alpha (low affinity) |
| 0.61 | 0.67 | −0.0 | 0.247 | 0.06* |
| PTGES | Prostaglandin E synthase |
| 0.46 | 0.57 | 0.86 | 0.03** | 0.09 | ||
| ICAM1 | Intercellular adhesion molecule 1 |
| 0.48 | 0.54 | −0.2 | 0.22 | 0.03** | ||
| Transport | 3 | GLG1 | Golgi apparatus protein 1 |
| 0.37 | −0.29 | 0.15 | 0.03** | 0.61 |
| GOLGA4 | Golgi autoantigen, golgin subfamily a, 4 |
| 0.29 | 0.36 | 1.03 | 0.11 | 0.69 | ||
| SLC31A1 | Solute carrier family 31 (copper transporters), member 1 |
| 0.32 | 0.4 | −0.1 | 0.04** | 0.11 | ||
| Diverse (extracellular matrix) | 1 | MMP7 | Matrix metalloproteinase 7 |
| 0.96 | −0.03 | 0.07* | 0.33 | |
| Diverse (lipid metabolism) | 1 | PLCL1 | Phospholipase C-like 1 |
| 0.49 | 0.77 | 0.33 | 0.86 | |
| Diverse (melanin metabolism) | 1 | SILV | Silver homolog (mouse) |
| 0.25 | −0.03 | 0.58 | 0.06* | 1 |
| Diverse (nucleus envelope) | 1 | LMNA | lamin A/C |
|
| 0.88 | 0.71 | 0.24 | 0.17 |
Those with bold characters correspond to those that were considered as significantly modulated as defined in the methods. If there were >0.9 = up-regulation, or if <−0.6 = down regulation. The young and aged data were compared at 6 and 30 h by mean of a Mann–Whitney test: * p value <0.1, ** p value <0.05
40 genes that were specifically modulated in aged skin based on D + 2sem: the mean fold change values at 6 and 30 h are reported at log2 scale
| Functional group | Total | Gene symbol | Gene name | Young | Aged |
| |||
|---|---|---|---|---|---|---|---|---|---|
| 6 h | 30 h | 6 h | 30 h | 6 h | 30 h | ||||
| Apoptosis | 1 | DAPK3 | Death-associated protein kinase 3 | 0.17 | 0.26 |
| −0.29 | 0.03** | 0.55 |
| Cell cycle, growth, proliferation | 2 | CDC37 | CDC37 (cell division cycle 37, | 1.02 | 0.51 | 0.74 |
| 0.55 | 0.11 |
| CDK2AP1 | Cyclin-dependent kinase 2-associated protein 1 | −0.07 | 0.00 | 0.51 |
| 0.53 | 0.08* | ||
| Cell differentiation | 1 | MDK | Midkine (neurite growth-promoting factor 2) | 0.68 | 0.50 | 0.53 |
| 0.66 | 0.01** |
| Cellular matrix | 3 | ARPC4 | Actin-related protein 2/3 complex, subunit 4 (20 kDa) | 0.11 | 0.84 |
| 0.286 | 0.04** | |
| NID1 | Nidogen_(entactin) | −0.07 | 0.03 | −0.06 |
| 0.429 | 0.01** | ||
| GSN | Gelsolin_(amyloidosis,_Finnish_type) | 1.35 | 0.04 | −0.39 |
| 0.01** | 0.01** | ||
| Communication | 9 | ITPKC | Inositol 1,4,5-trisphosphate 3-kinase C | 0.89 | 0.43 | 0.47 |
| 0.25 | 0.01** |
| MAP3K5 | Mitogen-activated protein kinase kinase 5 kinase 51activated_protein_kinase_kinase_kinase_5 | −0.18 | −0.16 | 0.15 |
| 0.931 | 0.03** | ||
| PIK3CD | Phosphoinositide-3kinase,_catalytic,_delta_polypeptide | −0.01 | −0.04 | 0.15 |
| 0.43 | 0.03** | ||
| PRKCG | Protein kinase C, gamma | 0.05 | −0.09 | −0.02 |
| 0.25 | 0.02** | ||
| FGA | fibrinogen, A alpha polypeptide | 0.88 | 0.30 | 0.75 |
| 0.79 | 0.01** | ||
| TLE4 | Transducin-like enhancer of split 4, homolog of Drosophila E(sp1) | 0.99 | 0.28 | 0.72 |
| 1 | 0.00** | ||
| TSPAN3 | Tetraspanin 3 | 0.86 | 0.70 | 0.46 |
| 0.11 | 0.11 | ||
| TRIO | Triple functional domain (PTPRF interacting) | 1.49 | 0.42 | 0.79 |
| 0.33 | 0.11 | ||
| ANXA6 | Annexin A6 | 1.02 | 0.37 | 0.59 |
| 0.43 | 0.18 | ||
| Detoxification–oxidative stress | 5 | COX7B | Cytochrome | 0.52 | 0.82 | 1.30 |
| 0.90 | 0.04** |
| COX7C | Cytochrome | 1.18 | 0.56 | 0.78 |
| 0.93 | 0.03** | ||
| CYC1 | Cytochrome | 0.49 | 0.63 |
| 1 | 0.04** | |||
| UQCRQ | Ubiquinol-cytochrome | 0.71 | 0.55 | 0.67 |
| 0.90 | 0.01** | ||
| GPX3 | Glutathione_peroxidase_3_(plasma) | −0.05 | 0.03 | 0.26 |
| 0.66 | 0.00** | ||
| DNA–RNA–transcription–translation | 8 | CBX3 | Human heterochromatin protein_HP1Hs-gamma_mRNA | 0.04 | 0.07 | 0.15 |
| 0.33 | 0.09* |
| MCRS1 | Microspherule protein 1 | 0.19 | −0.03 | 0.46 |
| 0.54 | 0.03** | ||
| POLR2G | Polymerase (RNA) II (DNA directed) polypeptide G | 1.10 | 0.44 | 0.60 |
| 0.43 | 0.00** | ||
| SF3B2 | Splicing factor 3b, subunit 2, 145 kDa | 1.23 | 0.56 | 0.78 |
| 0.55 | 0.02** | ||
| SNRPA1 | Small nuclear ribonucleoprotein polypeptide A′ | 0.70 | 0.23 | 0.83 |
| 1 | 0.04** | ||
| SSBP1 | Single-stranded DNA binding protein 1 | 1.16 | 0.43 |
|
| 0.25 | 0.02** | ||
| SUMO2 | small Ubiquitin-like Modifier type 2 | 0.01 | −0.12 | 0.46 |
| 1 | 0.00** | ||
| ESRRA | Estrogen-related_receptor_alpha | 0.18 | −0.05 | 0.12 |
| 0.66 | 0.08* | ||
| Energy | 1 | BPGM | 2,3-Bisphosphoglycerate_mutase | 0.17 | −0.14 | −0.04 |
| 0.43 | 0.05** |
| Immune response | 2 | TCRB | T-cell_receptor,_beta_cluster | 0.02 | 0.05 | 0.65 |
| 0.33 | 0.17 |
| CLEC2B | C-type lectin domain family 2, member B | 0.98 | 0.29 | 0.59 |
| 0.54 | 0.18 | ||
| Lipids (barrier function) | 1 | GBA | Glucosidase,_beta;_acid | 0.20 | −0.14 | 0.26 |
| 0.79 | 0.01** |
| Proteolysis | 2 | PSMA5 | Proteasome (prosome, macropain) subunit, alpha type, 5 | 1.16 | 0.62 |
|
| 1 | 0.05** |
| PSME2 | Proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 0.81 | 0.70 | 0.87 |
| 0.90 | 0.11 | ||
| Transport | 1 | ATP1A1 | ATPase, Na +/K + transporting, alpha 1 polypeptide | 0.65 | 0.61 | 0.81 |
| 0.63 | 0.02** |
| Diverse (oxygen transport) | 1 | NGB | Neuroglobin | 0.94 | 0.44 | 0.28 |
| 0.13 | 0.04** |
| Diverse (steroid metabolism) | 1 | HSD17B10 | Hydroxysteroid (17-beta) dehydrogenase 10 | 0.69 | 0.58 | 0.53 |
| 0.56 | 0.00** |
| Diverse (sugar binding) | 1 | LGALS2 | Lectin,_galactoside-binding,_soluble,_2_(galectin_2) | 0.14 | −0.07 | 0.22 |
| 0.54 | 0.01** |
| Diverse (vit K metabolism) | 1 | PRRG2 | Proline-rich_Gla_(G-carboxglutamic_acid)_polypeptide_2 | −0.14 | −0.08 | 0.03 |
| 1 | 0.01** |
Those with bold characters correspond to those that were considered as significantly modulated as defined in the “Methods”. If there were >0.9 = up-regulation, or if <−0.6 = down regulation. The young and aged data were compared at 6 and 30 h by mean of a Mann–Whitney test: * p value <0.1; ** p value <0.05